KURE · ARCA · ETF
KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings & Fees
KraneShares MSCI All China Health Care Index ETF (KURE) closed at $257.21 on Oct 9, 2026, down 0.05% from the previous close of $257.34.
Share price, past year
1Y +17.61%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $257.21 |
| Sep 30, 2026 | $256.79 |
| Aug 31, 2026 | $254.77 |
| Jul 31, 2026 | $229.51 |
| Jun 30, 2026 | $233.03 |
| May 29, 2026 | $227.55 |
| Apr 30, 2026 | $231.29 |
| Mar 31, 2026 | $236.75 |
| Feb 27, 2026 | $229.57 |
| Jan 30, 2026 | $217.03 |
| Dec 31, 2025 | $210.79 |
| Nov 28, 2025 | $213.34 |
| Oct 31, 2025 | $220.91 |
Key statistics
- Expense ratio
- 0.65%
- as of Jul 31, 2025
- Net assets
- $71.2M
- as of Jun 30, 2026
- Holdings
- 63
- as of Jun 30, 2026
- 52-week range
- $209.75 – $258.07
KraneShares MSCI All China Health Care Index ETF's expense ratio is 0.65%: $65.00 a year on $10,000 invested.
Holdings
KraneShares MSCI All China Health Care Index ETF held 63 investments worth $71.23M as of Jun 30, 2026. Its largest holding was BeOne Medicines AG, at 8.84% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | BeOne Medicines AG | 8.84% | $6.30M |
| 2 | INNOVENT BIOLOGICS, INC. | 8.80% | $6.27M |
| 3 | WUXI BIOLOGICS (CAYMAN) INC. | 7.51% | $5.35M |
| 4 | WuXi AppTec Co., Ltd. | 5.79% | $4.12M |
| 5 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.59% | $3.27M |
| 6 | Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.27% | $3.04M |
| 7 | Akeso Inc | 3.72% | $2.65M |
| 8 | CSPC PHARMACEUTICAL GROUP LIMITED | 3.68% | $2.62M |
| 9 | Invesco Government & Agency Portfolio | 3.55% | $2.53M |
| 10 | SINO BIOPHARMACEUTICAL LIMITED | 3.39% | $2.41M |
| 11 | WuXi AppTec Co., Ltd. | 3.35% | $2.39M |
| 12 | HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | 2.85% | $2.03M |
| 13 | 3SBio Inc. | 2.49% | $1.77M |
| 14 | YUNNAN BAIYAO GROUP CO., LTD | 2.30% | $1.64M |
| 15 | Shanghai United Imaging Healthcare Co., Ltd. | 2.27% | $1.62M |
| 16 | Aier Eye Hospital Group Co., Ltd. | 2.10% | $1.49M |
| 17 | Sichuan Biokin Pharmaceutical Co Ltd | 1.97% | $1.40M |
| 18 | Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | 1.85% | $1.32M |
| 19 | ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL CO., LTD. | 1.73% | $1.24M |
| 20 | SINOPHARM GROUP CO. LTD. | 1.67% | $1.19M |
| 21 | Sichuan Kelun Pharmaceutical Co., Ltd. | 1.55% | $1.10M |
| 22 | Haisco Pharmaceutical Group Co., Ltd. | 1.53% | $1.09M |
| 23 | HUADONG MEDICINE CO., LTD | 1.36% | $969.13K |
| 24 | WuXi XDC Cayman Inc | 1.35% | $963.92K |
| 25 | Shanghai Allist Pharmaceuticals Co Ltd | 1.34% | $954.42K |
Top 25 of 63 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.67% |
| Cash and short-term investments | 3.55% |
| Country | % of fund |
|---|---|
| Hong Kong | 52.67% |
| China | 45.73% |
| United States | 4.82% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, KraneShares MSCI All China Health Care Index ETF's total return was −7.56%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +2.01% |
| May 31, 2026 | −6.60% |
| Apr 30, 2026 | −2.98% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- KraneShares MSCI All China Health Care Index ETF
- Ticker
- KURE
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- Krane Shares Trust
- SEC series ID
- S000059796
- SEC CIK
- 0001547576
- Fractional shares
- Yes
Recent SEC filings
- Aug 28, 2026
- 485BPOSProspectus updateSep 21, 2026
- 485BPOSProspectus updateJul 29, 2026
- 485BPOSProspectus updateJul 13, 2026
- 485BPOSProspectus updateJul 2, 2026
- Jun 8, 2026
- Dec 3, 2025
Shareholder reports and prospectuses are filed by Krane Shares Trust, the trust behind KraneShares MSCI All China Health Care Index ETF, and cover all of its funds.
Frequently asked questions
What is KURE's price?
KraneShares MSCI All China Health Care Index ETF (KURE) closed at $257.21 on Oct 9, 2026, down 0.05% from the previous close of $257.34.
What is KURE's expense ratio?
KraneShares MSCI All China Health Care Index ETF's expense ratio is 0.65%: $65.00 a year on $10,000 invested.
What does KURE hold?
KraneShares MSCI All China Health Care Index ETF held 63 investments worth $71.23M as of Jun 30, 2026. Its largest holding was BeOne Medicines AG, at 8.84% of the fund. Its five largest holdings were BeOne Medicines AG, INNOVENT BIOLOGICS, INC., WUXI BIOLOGICS (CAYMAN) INC., WuXi AppTec Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,Ltd.
How has KURE performed?
Over the 3 months to Jun 30, 2026, KraneShares MSCI All China Health Care Index ETF's total return was −7.56%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 28, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Jul 31, 2025. Prices are generated sample data for development. Data sources and disclosures